Heparin-induced thrombocytopenia.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  New England Journal of Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11529227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heparin‐induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin

  2000cited by this paper
• Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.

  1997cited by this paper
• Anticoagulation with Novastan® (Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis Syndrome

  1997cited by this paper
• Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

  1996cited by this paper
• Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopenia

  1996cited by this paper
• A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.

  1996cited by this paper
• Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.

  1996cited by this paper
• Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.

  1996cited by this paper
• Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes.

  1996cited by this paper
• Comparing Subcutaneous Danaparoid with Intravenous Unfractionated Heparin for the Treatment of Venous Thromboembolism

  1995cited by this paper
• Meeting highlights.

  1995cited by this paper
• Acute myocardial infarction during coronary angioplasty associated with heparin-induced thrombocytopenia.

  1995cited by this paper
• Heparin associated thrombocytopenia.

  1995cited by this paper
• Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination.

  1995cited by this paper
• Heparin‐induced thrombocytopenia: cross‐reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran)

  1995cited by this paper
• Importance of PF4 in heparin-induced thrombocytopenia: confirmation with gray platelets.

  1995cited by this paper
• Use of recombinant hirudin as antithrombotic treatment in patients with heparin‐induced thrombocytopenia

  1995cited by this paper
• Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

  1995influential reference
• Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases

  1995cited by this paper
• Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.

  1995cited by this paper
• Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.

  1994cited by this paper
• Heparin-associated thrombosis despite normal platelet counts.

  1994cited by this paper
• Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.

  1994cited by this paper
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

  1994cited by this paper
• Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4.

  1994cited by this paper
• Heparin-Associated Thrombocytopenia: The Effects of Various Intravenous lgG Preparations on Antibody Mediated Platelet Activation - A Possible New Indication for High Dose i.v. IgG

  1994cited by this paper
• Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assay

  1994influential reference
• Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

  1994cited by this paper
• Heparin-associated thrombocytopenia: a critical review and pooled analysis.

  1993cited by this paper
• Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies

  1993influential reference
• Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia.

  1993cited by this paper
• The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia

  1993cited by this paper
• Hirudin therapy for heparin‐associated thrombocytopenia and deep venous thrombosis

  1993cited by this paper
• Further Evidence that Alpha-Granule Components such as Platelet Factor 4 Are Involved in Platelet-IgG-Heparin Interactions during Heparin-Associated Thrombocytopenia

  1993cited by this paper
• Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass.

  1993cited by this paper
• Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172)

  1993cited by this paper
• Heparin‐associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan

  1992cited by this paper
• Thrombocytopenia, cutaneous necrosis, and gangrene of the upper and lower extremities in a 35-year-old man.

  1992cited by this paper
• Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition.

  1992influential reference
• Heparin ‐ Induced Thrombocytopenia: Laboratory Investigation and Confirmation Of Diagnosis

  1992cited by this paper
• Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4)

  1992cited by this paper
• Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia

  1992cited by this paper
• Orgaran (Org 10172): its pharmacological profile in experimental models.

  1992cited by this paper
• Hospital liable for allergic reaction to heparin used in injection flush.

  1992cited by this paper
• Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific

  1992cited by this paper
• Acute adrenal insufficiency secondary to heparin–induced thrombocytopenia–thrombosis syndrome

  1992cited by this paper
• TREATMENT OF HEPARIN‐INDUCED THROMBOCYTOPENIA BY USE OF ARGATROBAN, A SYNTHETIC THROMBIN INHIBITOR

  1992cited by this paper
• Heparin‐induced thrombocytopenia and thrombosis: Reversal with streptokinase a case report and review of literature

  1991cited by this paper
• Adrenal hemorrhagic necrosis related to heparin-associated thrombocytopenia.

  1991cited by this paper
• Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

  1991cited by this paper
• A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia

  1991cited by this paper
• Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis

  1991cited by this paper
• Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis.

  1991cited by this paper
• Diagnostic and therapeutic strategies of white clot syndrome.

  1991cited by this paper
• Heparin-Induced Thrombocytopenia: A Case Report

  1990cited by this paper
• Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.

  1990cited by this paper
• Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis.

  1990cited by this paper
• Heparin-associated skin necrosis.

  1990cited by this paper
• Heparin and platelets.

  1990cited by this paper
• Intraoperative management of patients with heparin-induced thrombocytopenia.

  1990cited by this paper
• Correction of severe heparin-associated thrombocytopenia with intravenous immunoglobulin.

  1989cited by this paper
• Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.

  1989cited by this paper
• Lysed platelets shorten the activated coagulation time (ACT) of heparinized blood.

  1989cited by this paper
• Reexposure to heparin of patients with heparin-associated antibodies.

  1989cited by this paper
• Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

  1989cited by this paper
• Heparin-coated catheters and heparin-induced thrombocytopenia.

  1988cited by this paper
• Aspirin, heparin, or both to treat acute unstable angina.

  1988cited by this paper
• Thrombose intraventriculaire droite et thrombopénie à l'héparine.

  1988cited by this paper
• Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis.

  1988cited by this paper
• White clot syndrome.

  1988cited by this paper
• Heparin-induced thrombocytopenia: laboratory studies.

  1988cited by this paper
• Heparin-induced thrombocytopenia and thromboembolism in the postoperative period.

  1988cited by this paper
• Surgical management of heparin-associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism.

  1988cited by this paper
• Low molecular weight heparin fractions as an alternative therapy in heparin-induced thrombocytopenia.

  1987cited by this paper
• The relative contributions of antithrombin III during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.

  1987cited by this paper
• White clot syndrome associated with heparin-induced thrombocytopenia: a review of 23 cases.

  1987cited by this paper
• Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management.

  1987cited by this paper
• The heparin-induced thrombocytopenia syndrome: an update.

  1987influential reference
• Immune endothelial-cell injury in heparin-associated thrombocytopenia.

  1987cited by this paper
• Thrombolytic therapy in heparin-associated thrombocytopenia with thrombosis.

  1986cited by this paper
• Heparin-associated thrombocytopenia in the neurosurgical patient.

  1986cited by this paper
• Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism.

  1986cited by this paper
• A diagnostic test for heparin-induced thrombocytopenia.

  1986cited by this paper
• Heparin‐induced thrombocytopenia: further studies of the effects of heparin‐dependent antibodies on platelets

  1986cited by this paper
• Hypersensitivity reactions to heparin: delayed onset thrombocytopenia and necrotizing skin lesions.

  1986cited by this paper
• Heparin-associated thrombocytopenia: alternative managements.

  1986cited by this paper
• Heparin-Induced Thrombocytopenia and Pentosan Polysulfate: Treatment with a Low Molecular Weight Heparin Despite In Vitro Platelet Aggregation

  1986cited by this paper
• Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution.

  1986cited by this paper
• Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia.

  1985cited by this paper
• Heparin-associated thrombocytopenia: antibody binding specificity to platelet antigens.

  1985cited by this paper
• Heparin-induced thrombocytopenia and thrombosis: detection and specificity of a platelet-aggregating IgG.

  1985cited by this paper
• Treatment of Heparin-Associated Thrombocytopenia and Thrombosis with Low Molecular Weight Heparin (CY 216)

  1985cited by this paper
• Heparin-associated acute adrenal insufficiency.

  1985cited by this paper
• An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin.

  1985cited by this paper
• Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolism.

  1984cited by this paper
• Spontaneous platelet aggregation in heparin-treated patients.

  1984cited by this paper
• Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.

  1984cited by this paper
• Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation.

  1984cited by this paper
• Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase.

  1984cited by this paper
• Studies on the frequency of heparin-associated thrombocytopenia.

  1984cited by this paper

• Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment.

  2006cites this paper